Related Experiment Video
Updated: May 22, 2026

Left Atrial Ligation in the Avian Embryo as a Model for Altered Hemodynamic Loading During Early Vascular Development
Published on: June 16, 2023
Outcome and resource utilization of infants born with hypoplastic left heart syndrome in the Intermountain West
Shaji C Menon1, Heather T Keenan, Hsin-Yi Cindy Weng
1Division of Pediatric Cardiology, University of Utah, Salt Lake City, Utah, USA. shaji.menon@utah.edu
Insights
Hypoplastic left heart syndrome (HLHS) in the Intermountain West shows a 14-year transplant-free survival of 33%. Despite improved surgical palliation, HLHS infants face high mortality and significant healthcare resource utilization.
Area of Science:
- Pediatric Cardiology
- Congenital Heart Disease
- Public Health
Background:
- Hypoplastic left heart syndrome (HLHS) is a severe congenital heart defect.
- Outcomes and resource utilization for HLHS infants vary significantly.
- Population-based data are crucial for understanding the true burden of HLHS.
Purpose of the Study:
- To characterize the outcomes and resource utilization of all infants born with HLHS in the Intermountain West.
- To analyze trends in survival and identify risk factors for mortality.
- To assess lifetime hospitalization costs associated with HLHS management.
Main Methods:
- Retrospective cohort study of 245 infants born with HLHS between January 1995 and January 2010.
- Data divided into three eras (1995-1999, 2000-2004, 2005-2010) to assess temporal trends.
- Cox proportional hazards regression used to analyze mortality; lifetime hospitalization days and charges were determined.
Main Results:
- Overall 14-year transplant-free survival was 33%.
- 1-year transplant-free survival in the most recent era (2005-2010) was 60% for the surgical cohort.
- Risk factors for death included shock, chromosomal defects, and multiorgan dysfunction; improved survival associated with later birth era, higher birthweight, and gestational age.
Conclusions:
- Population-based studies reveal persistent high mortality and resource utilization for HLHS, despite hospital-based improvements in survival after surgical palliation.
- Factors such as shunt type, need for ECMO, renal dysfunction, and tricuspid valve regurgitation significantly impact post-stage 1 mortality.
- Median cumulative lifetime hospitalization costs ranged from $201,812 to $296,213 depending on the stage of palliation.
Abstract:
The objective of the present study was to characterize the outcomes and resource utilization of all infants born with hypoplastic left heart syndrome (HLHS) in the Intermountain West. This was a retrospective cohort study of all infants born with HLHS in the Intermountain West from January 1995 and January 2010. The cohort was divided into 3 eras: era 1, 1995 to 1999; era 2, 2000 to 2004; and era 3, 2005 to 2010. Cox proportional hazards regression analysis was performed to assess mortality. The lifetime hospitalization days and charges were also determined. Of the 245 infants identified, 65% were male infants and 172 (70%) underwent Stage 1 palliation. The transplant-free survival rate for the entire cohort was 33% at 14 years. The 1-year transplant-free survival rate for the surgical cohort was 60% in era 3. The infants whose initial presentation included shock, restrictive or intact atrial septum, chromosomal defects, or multiorgan dysfunction had an increased risk of death. A recent era of birth, greater birthweight, and older gestational age were associated with improved survival. The factors associated with mortality after stage 1 included surgical procedure type (Blalock-Taussig vs Sano shunt, hazard ratio 2.1), requirement for postoperative extracorporeal membrane oxygenation (hazard ratio 4.2), postoperative renal dysfunction (hazard ratio 3.0), anomalous pulmonary venous return (hazard ratio 2.9), and moderate or greater tricuspid valve regurgitation at any point (hazard ratio 2.0). For patients who had undergone stage 1, 2, or 3 palliation, the median cumulative lifetime hospitalization was 32, 48, and 65 days, and the median cumulative lifetime charges for hospitalization were $201,812, $253,183, and $296,213, respectively. In conclusion, although hospital-based studies of HLHS have shown significantly improved survival after surgical palliation, population-based studies have shown that HLHS continues to have a high mortality and high resource utilization.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
